LNTH FY 2017 Earnings — Lantheus Holdings, Inc. Revenue & Financial Results | Market Cap Arena

LNTHLantheus Holdings, Inc.

$5B

FY 2017 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$331M+9.8% YoY

Gross Profit

$162M48.9% margin

Operating Income

$52M15.6% margin

Net Income

$123M37.2% margin

EPS (Diluted)

$3.17

Cash Flow

Operating Cash Flow

$55M

Free Cash Flow

$37M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$384M

Total Liabilities

$361M

Stockholders' Equity

$23M

Cash & Equivalents

$76M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$331M	$302M	+9.8%
Gross Profit	$162M	$138M	+17.7%
Operating Income	$52M	$57M	-8.4%
Net Income	$123M	$27M	+361.0%